Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Liu, XinxueMunro, Alasdair Ps
Feng, Shuo
Janani, Leila
Aley, Parvinder K
Babbage, Gavin
Baxter, David
Bula, Marcin
Cathie, Katrina
Chatterjee, Krishna
Dejnirattisai, Wanwisa
Dodd, Kate
Enever, Yvanne
Qureshi, Ehsaan
Goodman, Anna L
Green, Christopher A
Harndahl, Linda
Haughney, John
Hicks, Alexander
van der Klaauw, Agatha A
Kwok, Jonathan
Libri, Vincenzo
Llewelyn, Martin J
McGregor, Alastair C
Minassian, Angela M
Moore, Patrick
Mughal, Mehmood
Mujadidi, Yama F
Holliday, Kyra
Osanlou, Orod
Osanlou, Rostam
Owens, Daniel R
Pacurar, Mihaela
Palfreeman, Adrian
Pan, Daniel
Rampling, Tommy
Regan, Karen
Saich, Stephen
Serafimova, Teona
Saralaya, Dinesh
Screaton, Gavin R
Sharma, Sunil
Sheridan, Ray
Sturdy, Ann
Supasa, Piyada
Thomson, Emma C
Todd, Shirley
Twelves, Chris
Read, Robert C
Charlton, Sue
Hallis, Bassam
Ramsay, Mary
Andrews, Nick
Lambe, Teresa
Nguyen-Van-Tam, Jonathan S
Cornelius, Victoria
Snape, Matthew D
Faust, Saul N
Publication date
2023-04-12Subject
Communicable diseases
Metadata
Show full item recordAbstract
No abstract availableCitation
Liu X, Munro AP, Feng S, Janani L, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K, Dejnirattisai W, Dodd K, Enever Y, Qureshi E, Goodman AL, Green CA, Harndahl L, Haughney J, Hicks A, van der Klaauw AA, Kwok J, Libri V, Llewelyn MJ, McGregor AC, Minassian AM, Moore P, Mughal M, Mujadidi YF, Holliday K, Osanlou O, Osanlou R, Owens DR, Pacurar M, Palfreeman A, Pan D, Rampling T, Regan K, Saich S, Serafimova T, Saralaya D, Screaton GR, Sharma S, Sheridan R, Sturdy A, Supasa P, Thomson EC, Todd S, Twelves C, Read RC, Charlton S, Hallis B, Ramsay M, Andrews N, Lambe T, Nguyen-Van-Tam JS, Cornelius V, Snape MD, Faust SN; COV-BOOST study group. Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511]. J Infect. 2023 May;86(5):540-541. doi: 10.1016/j.jinf.2023.03.025. Epub 2023 Apr 12. Erratum for: J Infect. 2022 Jun;84(6):795-813Type
ArticleAdditional Links
http://www.sciencedirect.com/science/journal/01634453PMID
37055303Journal
Journal of InfectionPublisher
Academic Pressae974a485f413a2113503eed53cd6c53
10.1016/j.jinf.2023.03.025